Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)

Stopped The study was suspended after a suspected unexpected serious adverse event.

Conditions

• Renal Insufficiency, Chronic
• Kidney Diseases

Interventions

• DRUG: Calcium EDTA
• DRUG: Gd-DOTA

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

• [object Object]